142 related articles for article (PubMed ID: 29843135)
1. Circulating α-Klotho is Related to Plasma Aldosterone and Its Follow-Up Change Predicts CKD Progression.
Qian J; Zhong J; Yan M; Cheng P; Shi H; Hao C; Gu Y; Lai L
Kidney Blood Press Res; 2018; 43(3):836-846. PubMed ID: 29843135
[TBL] [Abstract][Full Text] [Related]
2. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
3. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS
J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
[TBL] [Abstract][Full Text] [Related]
6. The association between serum soluble Klotho and chronic kidney disease among us adults ages 40 to 79 years: Cross-sectional study.
Zhang Z; Zhou X; Deng L; Jin K; Xiong X; Su X; Qiu S; Yang L
Front Public Health; 2022; 10():995314. PubMed ID: 36276390
[TBL] [Abstract][Full Text] [Related]
7. Correlation between Soluble
Wang Q; Su W; Shen Z; Wang R
Biomed Res Int; 2018; 2018():9481475. PubMed ID: 30159331
[TBL] [Abstract][Full Text] [Related]
8. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
[TBL] [Abstract][Full Text] [Related]
9. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
Milovanov YS; Mukhin NA; Kozlovskaya LV; Milovanova SY; Markina MM
Ter Arkh; 2016; 88(6):21-25. PubMed ID: 27296257
[TBL] [Abstract][Full Text] [Related]
10. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
11. [Decreased Serum Levels of Klotho Protein in Chronic Kidney Disease Patients: Clinical Imortance].
Milovanova LY; Mukhin NA; Kozlovskaya LV; Milovanov YS; Kiyakbaev GG; Rogova IV; Lebedeva MV; Androsova TV; Milovanova SY; Gil AY; Taranova MV
Vestn Ross Akad Med Nauk; 2016; 71(4):288-96. PubMed ID: 29297646
[TBL] [Abstract][Full Text] [Related]
12. Definitions of progression in chronic kidney disease--predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up.
Marks A; Fluck N; Prescott GJ; Robertson LM; Simpson WG; Smith WC; Black C
Nephrol Dial Transplant; 2014 Feb; 29(2):333-41. PubMed ID: 24081862
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor alpha (TNFα) and alpha-Klotho (αKL) in children and adolescents with chronic kidney disease (CKD).
Gamrot Z; Adamczyk P; Świętochowska E; Roszkowska-Bjanid D; Gamrot J; Szczepanska M
Endokrynol Pol; 2021; 72(6):625-633. PubMed ID: 34647605
[TBL] [Abstract][Full Text] [Related]
14. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
[TBL] [Abstract][Full Text] [Related]
15. Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.
Kanda E; Ai M; Okazaki M; Yoshida M; Maeda Y
PLoS One; 2016; 11(11):e0166459. PubMed ID: 27861640
[TBL] [Abstract][Full Text] [Related]
16. Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.
Liabeuf S; Ryckelynck JP; El Esper N; Ureña P; Combe C; Dussol B; Fouque D; Vanhille P; Frimat L; Thervet E; Mentaverri R; Prié D; Choukroun G;
Clin J Am Soc Nephrol; 2017 Dec; 12(12):1930-1940. PubMed ID: 29074818
[TBL] [Abstract][Full Text] [Related]
17. Influence of exogenous growth hormone administration on circulating concentrations of α-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study.
Adema AY; de Roij van Zuijdewijn CLM; Hoenderop JG; de Borst MH; Ter Wee PM; Heijboer AC; Vervloet MG;
BMC Nephrol; 2018 Nov; 19(1):327. PubMed ID: 30442108
[TBL] [Abstract][Full Text] [Related]
18. Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease.
Hamada K; Taniguchi Y; Shimamura Y; Inoue K; Ogata K; Ishihara M; Horino T; Fujimoto S; Ohguro T; Yoshimoto Y; Ikebe M; Yuasa K; Hoshino E; Iiyama T; Ichihara A; Terada Y
Clin Exp Nephrol; 2013 Dec; 17(6):848-56. PubMed ID: 23564382
[TBL] [Abstract][Full Text] [Related]
19. Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.
Schaefer F; Trachtman H; Wühl E; Kirchner M; Hayek SS; Anarat A; Duzova A; Mir S; Paripovic D; Yilmaz A; Lugani F; Arbeiter K; Litwin M; Oh J; Matteucci MC; Gellermann J; Wygoda S; Jankauskiene A; Klaus G; Dusek J; Testa S; Zurowska A; Caldas Afonso A; Tracy M; Wei C; Sever S; Smoyer W; Reiser J;
JAMA Pediatr; 2017 Nov; 171(11):e172914. PubMed ID: 28873129
[TBL] [Abstract][Full Text] [Related]
20. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
